<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Transl Androl Urol</journal-id><journal-id journal-id-type="iso-abbrev">Transl Androl Urol</journal-id><journal-id journal-id-type="publisher-id">TAU</journal-id><journal-title-group><journal-title>Translational Andrology and Urology</journal-title></journal-title-group><issn pub-type="epub">2223-4691</issn><publisher><publisher-name>AME Publishing Company</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29238659</article-id><article-id pub-id-type="pmc">5715174</article-id><article-id pub-id-type="publisher-id">tau-06-S5-S797</article-id><article-id pub-id-type="doi">10.21037/tau.2017.04.26</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>The use of penile prostheses in the management of priapism</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Moore</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Whelan</surname><given-names>Thomas F.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Langille</surname><given-names>Gavin M.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Urology, <institution>Dalhousie University</institution>, <addr-line>Halifax, NS</addr-line>, <country>Canada</country>;</aff><aff id="aff2"><label>2</label>Department of Urology, <institution>Dalhousie University</institution>, <addr-line>Saint John, NB</addr-line>, <country>Canada</country></aff></contrib-group><author-notes><fn id="afn1"><p><italic>Contributions:</italic> (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.</p></fn><corresp id="cor1"><italic>Correspondence to:</italic> Gavin M. Langille, MD, FRCSC. Department of Urology, Dalhousie University, 3DN Suite E, 400 University Avenue, Saint John, New Brunswick, E2L-4L2, Canada. Email: <email xlink:href="gavin.langille@gmail.com">gavin.langille@gmail.com</email>.</corresp></author-notes><pub-date pub-type="epub-ppub"><month>11</month><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>11</month><year>2017</year></pub-date><volume>6</volume><issue>Suppl 5</issue><fpage>S797</fpage><lpage>S803</lpage><history><date date-type="received"><day>30</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>12</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>2017 Translational Andrology and Urology. All rights reserved.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Translational Andrology and Urology.</copyright-holder></permissions><abstract><p>Priapism is a relatively uncommon condition that can result in erectile dysfunction (ED) and corporal fibrosis. Cases of prolonged priapism are particularly prone to ED, which arises when priapism is treatment refractory or had a delayed presentation. Due to the emergent nature of priapism, it behooves urologists to be familiar with all potential treatment modalities to minimize adverse outcomes. In this review paper, we aim to summarize the literature regarding the use of penile prosthesis (PP) implantation in the setting of ischemic priapism (IP). In some patients who present later or have prolonged initial treatment, early insertion of PP may be indicated.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>Priapism</kwd><kwd>penile prosthesis (PP)</kwd><kwd>erectile dysfunction (ED)</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The definition of priapism is a full or partial erection that persists beyond or occurs unrelated to sexual stimulation. The traditional cut-off is four hours or more in duration (<xref rid="r1" ref-type="bibr">1</xref>). Priapism is relatively rare, with an incidence of 0.5&#x02013;0.9 cases per 100,000 person years (<xref rid="r1" ref-type="bibr">1</xref>). These numbers are thought to be increasing related to the introduction of intercavernosal injections for erectile dysfunction (ED) (<xref rid="r2" ref-type="bibr">2</xref>).</p><p>Three subtypes of priapism exist: stuttering, non-ischemic, and ischemic (<xref rid="r1" ref-type="bibr">1</xref>). Stuttering priapism refers to recurrent, painful and unwanted erections that happen more commonly in patients with sickle cell disease or those with a history of ischemic priapism (IP). Non-IP is also known as high flow priapism; unregulated cavernosal arterial inflow causes a semi-rigid, non-painful erection. It can be related to an arteriolar-sinusoidal fistula from prior trauma or iatrogenic causes. Management is expectant in most cases of high flow priapism, but some patients require arterial embolization or ligation of the fistula. Ischemic or low-flow priapism is characterized by the lack of arterial blood flow, which can be assessed by Doppler ultrasound or inferred from cavernosal blood gas measurements. Patients typically have a painful, rigid penis. There are many potential underlying etiologies for IP including medication induced, infection, neoplasm, metabolic disorders, hematologic, neurologic, and idiopathic.</p></sec><sec><title>First line treatment of IP</title><p>The treatment algorithm for IP involves a stepwise approach from corporal aspiration and saline irrigation, and if required injection of alpha agonists such as phenylephrine (<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r3" ref-type="bibr">3</xref>). Cases refractory to these steps proceed to distal then proximal shunting procedures to establish flow between the corpus cavernosum and spongiosum. Lue <italic>et al</italic>. has hypothesised that the addition of upfront anticoagulation may improve outcomes for distal shunting. This may be due to improved blood flow across the shunt (<xref rid="r4" ref-type="bibr">4</xref>). Furthermore, proximal shunts may be less effective, again, because of a lack of sufficient blood flow (<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>). There is overall little to no evidence to show superiority of one type of shunt over another. Currently the AUA and EAU both recommend a proceeding from a distal to a proximal shunt in the patient with IP.</p><p>Emergency management of IP is indicated due to the rapid evolution of irreversible changes in the erectile tissues (<xref rid="r1" ref-type="bibr">1</xref>). Within hours there is onset of edema. Progressive destruction of sinusoidal endothelial cells and thrombocyte adherence can be seen at 24 hours. By 48 hours thrombi form in the sinusoidal spaces. At that point, complete smooth muscle necrosis or transformation to fibroblast-like cells is nearly universally present (<xref rid="r7" ref-type="bibr">7</xref>).The natural history of IP helps explain the increasing rates ED as the duration of priapism increases. Once tissue necrosis occurs, alpha agonist agents can no longer influence smooth muscle contraction (<xref rid="r8" ref-type="bibr">8</xref>).</p><p>In cases of prolonged IP, there have been a number studies looking at the efficacy of shunt procedures. A series by Brant <italic>et al</italic>. (<xref rid="r9" ref-type="bibr">9</xref>) have shown success using an approach of distal, bilateral T-shunting and corporal snaking in 13 patients, even after 36 hours. Among the 11 patients who presented at least 1.5 days or 36 hours after presentation, 5 (46%) had scores of 4 or 5 on the most clinically significant SHIM questions, numbers 2 and 3. The authors attribute the improved outcomes of their technique over standard distal shunting to the larger channel for drainage for the old, sludge-like blood in the corpora created by the tunnelling (<xref rid="r9" ref-type="bibr">9</xref>). Subsequent series, however, have been unable to replicate their results. In a series of 45 patients treated with T-shunt and corporal snake maneuver by Zacharakis <italic>et al</italic>. (<xref rid="r10" ref-type="bibr">10</xref>), rates of ED were high. Also, degree of ED was correlated with the duration of ischemia based on International Index of Erectile Function (IIEF-5) scores 6 months after treatment of the episode. Any grade of ED (IIEF-5 score less than 22) was seen in 100% men after 36 hours of IP and this advanced to severe ED (IIEF-5 less than 7) after 48 hours in all patients in their series. Additional, smaller series (<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r13" ref-type="bibr">13</xref>) of 3&#x02013;12 patients demonstrated that none of the patients had spontaneous erectile function post-priapism when presenting greater than 36 hours post-onset. In one of the studies (<xref rid="r11" ref-type="bibr">11</xref>), however, the duration was significantly longer with a mean 75 hours. Only eight of the ten had resolution of the priapism and associated symptoms with the procedure in that same study. Comparisons between all the studies are hampered by the heterogeneity of the patients, small numbers, and, in the case of the final study, by a longer mean duration of priapism.</p><p>Patients with previous episodes of prolonged priapism have high rates of ED and corporal fibrosis. Some authors have concluded that penile prosthesis (PP) insertion is often required in this population to allow erections sufficiently rigid for penetration ED (<xref rid="r10" ref-type="bibr">10</xref>). European Urology Association guidelines (<xref rid="r1" ref-type="bibr">1</xref>) currently recommend that in cases of priapism that present after 36 hours resistant to first line treatments including shunting procedures, ED is inevitable. Immediate PP insertion is recommended to avoid the corporal fibrosis associated with later insertion. The AUA guidelines on priapism, last updated 2003, do not discuss the use of PP for refractory IP (<xref rid="r3" ref-type="bibr">3</xref>). They do, however, list PP as a last resort for stuttering priapism. The use of PP in refractory IP will be discussed below.</p></sec><sec><title>Corporal fibrosis</title><p>One of the main challenges for surgeons offering a PP for the post-priapism patient is corporal fibrosis, which leads to higher perioperative complication rates (<xref rid="r14" ref-type="bibr">14</xref>). During IP, corporal tissue can be replaced with a dense fibrotic scar (<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r15" ref-type="bibr">15</xref>). Other etiologies associated with corporal fibrosis include Peyronie&#x02019;s disease, penile trauma, and infected penile implants (<xref rid="r16" ref-type="bibr">16</xref>). Distal fibrosis is more likely to occur in patients with a history of priapism while infection more often causes scar in the proximal corpora (<xref rid="r15" ref-type="bibr">15</xref>).</p><p>Multiple treatment options have been explored to address corporal fibrosis during PP insertion. The use of cavernotomes (<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>), direct excisions of scar (<xref rid="r19" ref-type="bibr">19</xref>), corporotomies with or without allografting (<xref rid="r20" ref-type="bibr">20</xref>-<xref rid="r25" ref-type="bibr">25</xref>) endoscopic excision (<xref rid="r26" ref-type="bibr">26</xref>,<xref rid="r27" ref-type="bibr">27</xref>), and &#x0201c;tissue expansion&#x0201d; with downsized implants (<xref rid="r15" ref-type="bibr">15</xref>) have been described. Complication rates for these procedures are reportedly significant. Intraoperative complications include urethral injuries and corporeal perforation (<xref rid="r15" ref-type="bibr">15</xref>). Late complications include infection, erosion, mechanical failure, penile shortening, and autoinflation (<xref rid="r28" ref-type="bibr">28</xref>). In one review, corporotomies with or without grafting resulted in a 30% early complication rate, and 50&#x02013;65% of patients have late complications (<xref rid="r16" ref-type="bibr">16</xref>). Despite this, patient reported outcomes show 71&#x02013;100% (<xref rid="r29" ref-type="bibr">29</xref>) of patients being satisfied with results. Primary patient complaints are of penile shortening, altered sensation, pain, decreased glanular engorgement and poor cosmetic result (<xref rid="r29" ref-type="bibr">29</xref>).</p><p>In a series by Durazi <italic>et al</italic>. (<xref rid="r30" ref-type="bibr">30</xref>), 17 patients had a PP placed 6&#x02013;18 months after an episode of IP. Extensive corporal fibrosis was managed with sharp excision. There were two urethral injuries managed with primary closure. Patients who went to the OR before and after 1 year from the time of IP episode had surgical operative times of 30&#x02013;60 and 60&#x02013;180 min, respectively. There were no late complications or reoperations and 16 of 17 patients were sexually active on follow-up. One group suggests using the smaller, narrower inflatable cylinders as tissue expanders which can be upsized 8&#x02013;12 months later. Thirty-seven patients with corporal fibrosis received Mentor Narrow Base or AMS CXR/M (American Medical Systems Minnetonka, MN, USA), 8 of which were post-priapism (<xref rid="r15" ref-type="bibr">15</xref>). There was a 54% chance of dilator perforation at time of surgery and 30% had impending cylinder erosion during the second stage surgery. The post IP group was able to tolerate upsizing to wider cylinders, but no upsizing of implant length was possible. In contrast the group with fibrosis not due to IP had both longer and wider cylinders inserted at the second stage surgery. These findings highlight the potential for irreversible loss of length for patients with corporal fibrosis post IP.</p></sec><sec><title>Timing of insertion</title><p>There is a growing body of research looking at early insertion of PP after an episode of IP (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r31" ref-type="bibr">31</xref>-<xref rid="r34" ref-type="bibr">34</xref>). In published studies, the timing of an early insertion ranges from 24&#x02013;720 hours after onset of priapism (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r31" ref-type="bibr">31</xref>-<xref rid="r34" ref-type="bibr">34</xref>). Suggested benefits include decreased penile shortening (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r31" ref-type="bibr">31</xref>,<xref rid="r32" ref-type="bibr">32</xref>), decreased complication rates (<xref rid="r34" ref-type="bibr">34</xref>), easier operative technique (<xref rid="r30" ref-type="bibr">30</xref>,<xref rid="r31" ref-type="bibr">31</xref>,<xref rid="r33" ref-type="bibr">33</xref>,<xref rid="r34" ref-type="bibr">34</xref>), shorter operative time (<xref rid="r30" ref-type="bibr">30</xref>), and decreased cost (<xref rid="r35" ref-type="bibr">35</xref>). Many of the proposed advantages stem from the avoidance of severe corporal fibrosis. In the setting of a patient with severe baseline ED who presents with priapism, an early implant may offer a single solution for both issues (<xref rid="r31" ref-type="bibr">31</xref>). A summary of outcomes and complications for early insertion of PP after IP are listed in <xref ref-type="table" rid="t1"><italic>Table 1</italic></xref>. Studies are limited to a single cohort study and multiple case series.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Summary of studies of early implantation of inflatable penile prosthesis after episode of priapism</title></caption><table frame="hsides" rules="groups"><col width="10.36%" span="1"/><col width="3.61%" span="1"/><col width="4.12%" span="1"/><col width="8.24%" span="1"/><col width="6.18%" span="1"/><col width="5.15%" span="1"/><col width="9.79%" span="1"/><col width="4.63%" span="1"/><col width="6.8%" span="1"/><col width="8.56%" span="1"/><col width="7.31%" span="1"/><col width="25.25%" span="1"/><thead><tr><th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Study</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">No. patients</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">No. treated early</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Duration of priapism, hours [mean]</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Implant type, malleable, %</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Mean F/U, months</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Intraoperative complications</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Infection, %</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Reoperation<sup>&#x02020;</sup>, %</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Shortening</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Satisfaction, %</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">Notes</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rees <italic>et al.</italic> 2002 (<xref rid="r31" ref-type="bibr">31</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">32&#x02013;192 [91]</td><td valign="top" align="center" rowspan="1" colspan="1">75</td><td valign="top" align="center" rowspan="1" colspan="1">17</td><td valign="top" align="center" rowspan="1" colspan="1">None</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">12.5</td><td valign="top" align="center" rowspan="1" colspan="1">None</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sedigh <italic>et al.</italic> 2011 (<xref rid="r32" ref-type="bibr">32</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">72&#x02013;480 [NR]</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">One urethral perforation</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">No complaint</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="left" rowspan="1" colspan="1">IIEF-Q5 mean of 4</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ralph <italic>et al.</italic> 2009 (<xref rid="r28" ref-type="bibr">28</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">50</td><td valign="top" align="center" rowspan="1" colspan="1">50</td><td valign="top" align="center" rowspan="1" colspan="1">24&#x02013;720 [209]</td><td valign="top" align="center" rowspan="1" colspan="1">86</td><td valign="top" align="center" rowspan="1" colspan="1">15.7</td><td valign="top" align="center" rowspan="1" colspan="1">None</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">No complaint</td><td valign="top" align="center" rowspan="1" colspan="1">96</td><td valign="top" align="left" rowspan="1" colspan="1">Erosion all post distal shunt</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Salem <italic>et al.</italic> 2010 (<xref rid="r33" ref-type="bibr">33</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">60&#x02013;168 [120]</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">One corporeal perforation</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="left" rowspan="1" colspan="1">Sling suture to prevent distal erosion</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Zacharakis <italic>et al.</italic> 2014 (<xref rid="r34" ref-type="bibr">34</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">68</td><td valign="top" align="center" rowspan="1" colspan="1">24&#x02013;408 [168]</td><td valign="top" align="center" rowspan="1" colspan="1">94</td><td valign="top" align="center" rowspan="1" colspan="1">17</td><td valign="top" align="center" rowspan="1" colspan="1">None</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">3% reporting</td><td valign="top" align="center" rowspan="1" colspan="1">96</td><td valign="top" align="left" rowspan="1" colspan="1">Delayed group: infection =19%, shortening =40%, satisfaction =60%</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tausch <italic>et al.</italic> 2015 (<xref rid="r35" ref-type="bibr">35</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">NR [82]</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="left" rowspan="1" colspan="1">Cost analysis done</td></tr></tbody></table><table-wrap-foot><p>NR, not reported; IIEF-5, international index of erectile function questionnaire; &#x02020;, other than for elective exchange to inflatable; F/U, follow up.</p></table-wrap-foot></table-wrap><p>In series that used early insertion of PP, data on penile length is poorly reported. Rees <italic>et al</italic>. (<xref rid="r31" ref-type="bibr">31</xref>) describes a subjective maintenance of penile length with no quantitative or qualitative data. In a non-randomized, observational study by Zacharakis <italic>et al</italic>. (<xref rid="r34" ref-type="bibr">34</xref>) 95 men had PP placed after IP. 68 received PP in the first 7 days after IP, the rest of the group received an implant 5 months post IP. Patient reported outcome of low sexual satisfaction were 40% and 3% for the delayed and early operative group, respectively (P&#x0003c;0.001). Sedigh <italic>et al</italic>. report the outcomes of 20 patients with IP; five patients ultimately underwent early PP placement (<xref rid="r32" ref-type="bibr">32</xref>). The duration of priapism was 3&#x02013;20 days. A mean decrease in penile length of 3.5 cm was seen in those who did not undergo PP placement, versus no decrease in the PP group.</p><p>The types of complications observed in the early insertion groups are similar to those in the late insertion series (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r31" ref-type="bibr">31</xref>-<xref rid="r35" ref-type="bibr">35</xref>). The most common early complication was urethral perforation (0&#x02013;20%). When encountered, this was managed with primary closure at the time of the insertion (<xref rid="r32" ref-type="bibr">32</xref>,<xref rid="r33" ref-type="bibr">33</xref>). The indications for reoperation after early insertion were infection [6&#x02013;7% (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r34" ref-type="bibr">34</xref>)], erosion [0&#x02013;6% (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r34" ref-type="bibr">34</xref>)], short cylinders [4% (<xref rid="r28" ref-type="bibr">28</xref>)], autoinflation [2% (<xref rid="r28" ref-type="bibr">28</xref>)], and residual curvature [1&#x02013;2% (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r34" ref-type="bibr">34</xref>)]. In a series where 43 patients received a malleable device initially, six elected re-operation to exchange for an inflatable PP (28). Rates of revision were significantly less in patients who had early versus delayed PP placement [9% <italic>vs.</italic> 27%, P&#x0003c;0.03 (<xref rid="r34" ref-type="bibr">34</xref>)]. After distal shunting is performed, consideration for delaying PP placement is warranted due to concern over the risk of infection (<xref rid="r34" ref-type="bibr">34</xref>). In studies the by Ralph <italic>et al</italic>. (<xref rid="r28" ref-type="bibr">28</xref>) and Zacharakis <italic>et al</italic>. (<xref rid="r34" ref-type="bibr">34</xref>), only 34% and 38% of IP patients had a shunt prior to PP placement, respectively. They found that all patients who presented with infection either had a previous T-shunt (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r34" ref-type="bibr">34</xref>) or glans erosion (<xref rid="r34" ref-type="bibr">34</xref>). The duration of delay for PP placement after unsuccessful shunt surgery is suggested to be at least a &#x0201c;few days&#x0201d; to allow tissue healing, but no longer than 2 weeks to ensure ease of dilation prior to the onset of fibrosis (<xref rid="r34" ref-type="bibr">34</xref>). Ralph <italic>et al</italic>. suggest that bruising and edema is a contraindication to insertion of a three-piece inflatable prosthesis, and recommend malleable prosthesis in this setting (<xref rid="r28" ref-type="bibr">28</xref>). The finding of residual curvature appears to be correlated with inflatable devices that have not been cycled by the patient adequately (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r34" ref-type="bibr">34</xref>). If inflatable prostheses are used, early and frequent cycling is suggested to prevent curvature and contracture due to formation of a fibrotic capsule (<xref rid="r28" ref-type="bibr">28</xref>).</p><p>Salem <italic>et al</italic>. (<xref rid="r33" ref-type="bibr">33</xref>) developed a technique to reduce the rate of distal erosion in patients undergoing malleable PP insertion who have had a previous distal shunt for IP. Their hypothesis is that distal shunts and especially El-Ghorab shunts, weaken the distal corpora and put the patient at risk of distal erosion (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r33" ref-type="bibr">33</xref>). Their approach is to use a sling-like suture to stop distal device migration and erosion through the weakened tip after the distal shunt procedure. This is in place of the alternative approach, cited by the authors, of using a shorter cylinder that does not press on the shunt site, but may need to be exchanged for an appropriately sized one at a later date. Using a heavy, non-absorbable polypropylene suture, a tacking stitch is made through the corporotomy and the cylinder core. There was no distal erosion seen in their study of 12 patients. One patient did have a corporal perforation, but it was during the use of the Brooks dilators at the time of the original surgery.</p><p>Direct data on the technical difficulty of the insertion is mostly subjective. The early surgery is described in the literature as being an &#x0201c;easy dilation&#x0201d; (<xref rid="r33" ref-type="bibr">33</xref>,<xref rid="r34" ref-type="bibr">34</xref>) resulting in &#x0201c;rapid detumescence&#x0201d; (<xref rid="r31" ref-type="bibr">31</xref>) with &#x0201c;easy insertion&#x0201d; (<xref rid="r31" ref-type="bibr">31</xref>,<xref rid="r32" ref-type="bibr">32</xref>) of cylinders. Ralph <italic>et al</italic>. (<xref rid="r28" ref-type="bibr">28</xref>) state that the <italic>&#x0201c;&#x02026;operation was easily performed and usually took &#x0003c;60 min.</italic>&#x0201d; Surgical time was explored in one study in a more delayed setting. A series of 17 ED patients with delayed PP placement 6&#x02013;18 months after the IP episode describes difficult PP placement secondary to fibrosis (<xref rid="r30" ref-type="bibr">30</xref>). A malleable prosthesis (AMS 650, American Medical Systems Minnetonka, MN, USA) was placed in 11 patients, 2-piece Ambicor inflatable in four patients, and 3-piece 700CX in two patients. In that study, the difficulty of PP placement increased for patients undergoing surgery after 12 months post IP episode; the overall surgical time increased from 30&#x02013;60 to 60&#x02013;180 min before and after 12 months, respectively.</p><p>Patient satisfaction remains high after early insertion and ranges from 96&#x02013;100% (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r31" ref-type="bibr">31</xref>-<xref rid="r34" ref-type="bibr">34</xref>). Most reports base satisfaction on achievement of sexual intercourse alone (<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r31" ref-type="bibr">31</xref>,<xref rid="r33" ref-type="bibr">33</xref>,<xref rid="r34" ref-type="bibr">34</xref>). Sedigh <italic>et al</italic>. (<xref rid="r32" ref-type="bibr">32</xref>) reported a mean score of 4 out of 5 on question 5 of the IIEF-5 questionnaire, representing achievement of satisfactory sexual intercourse more than half of the time. Zacharakis <italic>et al</italic>. compared the sexual satisfaction of early and delayed insertion groups (<xref rid="r34" ref-type="bibr">34</xref>). Satisfaction was 90% <italic>vs.</italic> 60% in the early versus delayed group, respectively (P&#x0003c;0.001), with most the dissatisfaction arising from penile shortening.</p><p>Cost-effectiveness of early PP insertion in the setting of IP was explored in a study by Tausch <italic>et al</italic>. (<xref rid="r35" ref-type="bibr">35</xref>). Health care related costs were calculated for 14 men with refractory priapism who eventually received a PP. Average cost of care prior to PP insertion was $83,818 USD, including a mean of 4 ER visits, 2 hospital admissions, 1.5 shunts performed, 5 irrigation and phenylephrine injection procedures, and 6 days in hospital. Time to insertion of the device was 82 hours, on average. The cost of the implant itself was $3,850 USD. Patients were discharged within 24 hours after PP placement. Potential cost savings may exist if early PP implantation occurs, especially if it prevents potentially ineffective procedures in those who present later than 36&#x02013;48 hours after onset. Missing from their cost analysis is the delayed, significant cost of an eventual elective replacement of the malleable for inflatable prosthesis that some men may request. The authors note that their facility carries a stock of malleable prostheses to allow after hours or weekend implantation without having to contact sales representatives or manufacturers. Levey <italic>et al</italic>. (<xref rid="r36" ref-type="bibr">36</xref>) have suggested that financial coverage and truly informed consent may be barriers to early insertion.</p><p>Zacharakis <italic>et al</italic>. have suggested an accelerated algorithm for PP placement. (<xref rid="r34" ref-type="bibr">34</xref>) If onset of priapism is less than 48 hours, an attempt at shunting is recommended with concurrent smooth muscle biopsy. An unsuccessful shunt or presence of smooth muscle necrosis triggers PP insertion. All patients presenting after 72 hours are recommended for early PP under their proposal. Those within the 48&#x02013;72 hour window can have an MRI and penile duplex ultrasound assess perfusion. Lack of perfusion triggers PP insertion while distal shunting is suggested for those with perfusion.</p><p>We present the treatment algorithm for management of IP used at our institution (<xref ref-type="fig" rid="f1"><italic>Figure 1</italic></xref>). While this algorithm attempts to incorporate the available literature and guidelines regarding early PP placement, much of it relies on expert opinion. The successful of IP treatment relies on early recognition and treatment with first line therapies to maximize the ED outcomes and avoids the need for an invasive and permanent procedure in the form of PP. This algorithm serves to remind urologists that in certain instances, early PP placement should be discussed with the patient. The presence of pre-existing severe ED, evidence of smooth muscle necrosis, or priapism refractory to all other treatments should be considered for PP placement. Distal corporoglanular shunting procedures (once considered a mainstay of treatment for all IP patients) might be reconsidered in delayed presentations of IP, as these procedures can increase the risk of erosion and infection if subsequent PP insertion is performed. The definition of delayed priapism&#x02014;after which ED is inevitable&#x02014;is controversial and varies among studies. While most patients would have significant ED after 36 hours (<xref rid="r10" ref-type="bibr">10</xref>), some may still maintain function (<xref rid="r9" ref-type="bibr">9</xref>). It seems universal that patients presenting after 48 hours will have no erectile function (<xref rid="r10" ref-type="bibr">10</xref>). We therefore propose that if a patient presents greater than 48 hours after onset and is willing to have PP placed after appropriate counselling, that the distal shunt be omitted for those reasons. In addition, based on the information we know on the histological changes (<xref rid="r7" ref-type="bibr">7</xref>) and outcomes for delayed distal shunting (<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>), ED inevitable for these patients. For that reason, early PP insertion could avoid the complications associated with a delayed insertion secondary to corporal fibrosis. All procedures such as irrigation and shunting should be performed under sterile technique with the understanding that these patients may ultimately require PP placement. We theorize that proximal shunting (such as the Quackels or Sacher procedures) performed in the operative theater under sterile technique would have less risk of infection and erosion with subsequent PP insertion. Urologists must be aware of the limitations within the existing literature on this topic due to the emergent nature of IP and the possibility of medical-legal implications of poor outcomes. Clinicians must use clinically sound judgment and individualize treatments for patients with IP; no single treatment algorithm can definitively account for all medical scenarios.</p><fig id="f1" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Treatment algorithm for the management of ischemic priapism (IP) with a focus on the role of early penile prosthesis (PP) placement. The evidence for early PP placement is limited; relying heavily on case series and on expert opinion. When counselling parents regarding treatment options in the setting of IP, conversations must be tailored to include patient factors including goals of care and individual medical considerations.</p></caption><graphic xlink:href="tau-06-S5-S797-f1"/></fig></sec><sec sec-type="conclusions"><title>Conclusions</title><p>IP lasting longer than 48 hours usually results in severe corporal fibrosis, ED, and penile shortening. Implantation of a PP is often required to re-establish erectile function for these patients. Delayed PP insertion presents a difficult surgical challenge with worse patient outcomes due to significant corporal fibrosis. Patients with IP who fail less invasive management options, or with delayed IP presentation, should be counselled regarding the option of early PP implantation within 2 weeks of IP onset.</p></sec></body><back><ack><title>Acknowledgements</title><p>None.</p></ack><fn-group><fn fn-type="COI-statement"><p><italic>Conflicts of Interest:</italic> The authors have no conflicts of interest to declare.</p></fn></fn-group><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salonia</surname><given-names>A</given-names></name><name><surname>Eardley</surname><given-names>I</given-names></name><name><surname>Giuliano</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>European Association of Urology guidelines on priapism.</article-title>
<source>Eur Urol</source>
<year>2014</year>;<volume>65</volume>:<fpage>480</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2013.11.008</pub-id><pub-id pub-id-type="pmid">24314827</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broderick</surname><given-names>GA</given-names></name><name><surname>Kadioglu</surname><given-names>A</given-names></name><name><surname>Bivalacqua</surname><given-names>TJ</given-names></name><etal/></person-group>
<article-title>Priapism: pathogenesis, epidemiology, and management.</article-title>
<source>J Sex Med</source>
<year>2010</year>;<volume>7</volume>:<fpage>476</fpage>-<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2009.01625.x</pub-id><pub-id pub-id-type="pmid">20092449</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montague</surname><given-names>DK</given-names></name><name><surname>Jarow</surname><given-names>J</given-names></name><name><surname>Broderick</surname><given-names>GA</given-names></name><etal/></person-group>
<article-title>American Urological Association guideline on the management of priapism.</article-title>
<source>J Urol</source>
<year>2003</year>;<volume>170</volume>:<fpage>1318</fpage>-<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1097/01.ju.0000087608.07371.ca</pub-id><pub-id pub-id-type="pmid">14501756</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lue</surname><given-names>TF</given-names></name></person-group>
<article-title>Shunting for prolonged ischemic priapism: a 50-year mistake?</article-title>
<source>Transl Androl Urol</source>
<year>2014</year>;<volume>3</volume>:<fpage>AB06</fpage>.</mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>M</given-names></name><name><surname>Porten</surname><given-names>S</given-names></name><name><surname>Lue</surname><given-names>TF</given-names></name></person-group>
<article-title>Commentary on refractory ischemic priapism.</article-title>
<source>Transl Androl Urol</source>
<year>2012</year>;<volume>1</volume>:<fpage>61</fpage>-<lpage>5</lpage>.<pub-id pub-id-type="pmid">26813294</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovac</surname><given-names>JR</given-names></name><name><surname>Mak</surname><given-names>SK</given-names></name><name><surname>Garcia</surname><given-names>MM</given-names></name><etal/></person-group>
<article-title>A pathophysiology-based approach to the management of early priapism.</article-title>
<source>Asian J Androl</source>
<year>2013</year>;<volume>15</volume>:<fpage>20</fpage>-<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/aja.2012.83</pub-id><pub-id pub-id-type="pmid">23202699</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spycher</surname><given-names>MA</given-names></name><name><surname>Hauri</surname><given-names>D</given-names></name></person-group>
<article-title>The ultrastructure of the erectile tissue in priapism.</article-title>
<source>J Urol</source>
<year>1986</year>;<volume>135</volume>:<fpage>142</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(17)45549-2</pub-id><pub-id pub-id-type="pmid">3941454</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tausch</surname><given-names>TJ</given-names></name><name><surname>Mauck</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>LC</given-names></name><etal/></person-group>
<article-title>Penile prosthesis insertion for acute priapism.</article-title>
<source>Urol Clin North Am</source>
<year>2013</year>;<volume>40</volume>:<fpage>421</fpage>-<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.ucl.2013.04.010</pub-id><pub-id pub-id-type="pmid">23905940</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brant</surname><given-names>WO</given-names></name><name><surname>Garcia</surname><given-names>MM</given-names></name><name><surname>Bella</surname><given-names>AJ</given-names></name><etal/></person-group>
<article-title>T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism.</article-title>
<source>J Urol</source>
<year>2009</year>;<volume>181</volume>:<fpage>1699</fpage>-<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2008.12.021</pub-id><pub-id pub-id-type="pmid">19233430</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacharakis</surname><given-names>E</given-names></name><name><surname>Raheem</surname><given-names>AA</given-names></name><name><surname>Freeman</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism.</article-title>
<source>J Urol</source>
<year>2014</year>;<volume>191</volume>:<fpage>164</fpage>-<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2013.07.034</pub-id><pub-id pub-id-type="pmid">23892191</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segal</surname><given-names>RL</given-names></name><name><surname>Readal</surname><given-names>N</given-names></name><name><surname>Pierorazio</surname><given-names>PM</given-names></name><etal/></person-group>
<article-title>Corporal Burnett "Snake" surgical maneuver for the treatment of ischemic priapism: long-term followup.</article-title>
<source>J Urol</source>
<year>2013</year>;<volume>189</volume>:<fpage>1025</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2012.08.245</pub-id><pub-id pub-id-type="pmid">23017524</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnett</surname><given-names>AL</given-names></name><name><surname>Pierorazio</surname><given-names>PM</given-names></name></person-group>
<article-title>Corporal "snake" maneuver: corporoglanular shunt surgical modification for ischemic priapism.</article-title>
<source>J Sex Med</source>
<year>2009</year>;<volume>6</volume>:<fpage>1171</fpage>-<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2008.01176.x</pub-id><pub-id pub-id-type="pmid">19207268</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lian</surname><given-names>W</given-names></name><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Al-Ghorab Shunt plus intracavernous tunneling for prolonged ischemic priapism.</article-title>
<source>J Androl</source>
<year>2010</year>;<volume>31</volume>:<fpage>466</fpage>-<lpage>71</lpage>. <pub-id pub-id-type="doi">10.2164/jandrol.110.010132</pub-id><pub-id pub-id-type="pmid">20467049</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-Salamanca</surname><given-names>JI</given-names></name><name><surname>Mueller</surname><given-names>A</given-names></name><name><surname>Moncada</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Penile prosthesis surgery in patients with corporal fibrosis: a state of the art review.</article-title>
<source>J Sex Med</source>
<year>2011</year>;<volume>8</volume>:<fpage>1880</fpage>-<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2011.02281.x</pub-id><pub-id pub-id-type="pmid">21492405</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SK</given-names></name><name><surname>Delk</surname><given-names>JR</given-names><suffix>2nd</suffix></name><name><surname>Mulcahy</surname><given-names>JJ</given-names></name><etal/></person-group>
<article-title>Upsizing of inflatable penile implant cylinders in patients with corporal fibrosis.</article-title>
<source>J Sex Med</source>
<year>2006</year>;<volume>3</volume>:<fpage>736</fpage>-<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2006.00263.x</pub-id><pub-id pub-id-type="pmid">16839331</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yafi</surname><given-names>FA</given-names></name><name><surname>Sangkum</surname><given-names>P</given-names></name><name><surname>McCaslin</surname><given-names>IR</given-names></name><etal/></person-group>
<article-title>Strategies for penile prosthesis placement in Peyronie's disease and corporal fibrosis.</article-title>
<source>Curr Urol Rep</source>
<year>2015</year>;<volume>16</volume>:<fpage>21</fpage>. <pub-id pub-id-type="doi">10.1007/s11934-015-0491-0</pub-id><pub-id pub-id-type="pmid">25712763</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mooreville</surname><given-names>M</given-names></name><name><surname>Adrian</surname><given-names>S</given-names></name><name><surname>Delk</surname><given-names>JR</given-names><suffix>2nd</suffix></name><etal/></person-group>
<article-title>Implantation of inflatable penile prosthesis in patients with severe corporeal fibrosis: introduction of a new penile cavernotome.</article-title>
<source>J Urol</source>
<year>1999</year>;<volume>162</volume>:<fpage>2054</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(05)68099-8</pub-id><pub-id pub-id-type="pmid">10569568</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossell&#x000f3;</surname><given-names>Barbar&#x000e1; M</given-names></name><name><surname>Cavernotomy</surname><given-names>Carri&#x000f3;n H.</given-names></name></person-group>
<source>Arch Esp Urol</source>
<year>1991</year>;<volume>44</volume>:<fpage>185</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="pmid">1867494</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montague</surname><given-names>DK</given-names></name><name><surname>Angermeier</surname><given-names>KW</given-names></name></person-group>
<article-title>Corporeal excavation: new technique for penile prosthesis implantation in men with severe corporeal fibrosis.</article-title>
<source>Urology</source>
<year>2006</year>;<volume>67</volume>:<fpage>1072</fpage>-<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.urology.2005.11.001</pub-id><pub-id pub-id-type="pmid">16581112</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sansalone</surname><given-names>S</given-names></name><name><surname>Garaffa</surname><given-names>G</given-names></name><name><surname>Djinovic</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Simultaneous total corporal reconstruction and implantation of a penile prosthesis in patients with erectile dysfunction and severe fibrosis of the corpora cavernosa.</article-title>
<source>J Sex Med</source>
<year>2012</year>;<volume>9</volume>:<fpage>1937</fpage>-<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2012.02748.x</pub-id><pub-id pub-id-type="pmid">22672346</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>EJ</given-names></name><name><surname>Kuwano</surname><given-names>AY</given-names></name><name><surname>Guimaraes</surname><given-names>AN</given-names></name><etal/></person-group>
<article-title>Corporoplasty using bovine pericardium grafts in complex penile prosthesis implantation surgery.</article-title>
<source>Int Braz J Urol</source>
<year>2009</year>;<volume>35</volume>:<fpage>49</fpage>-<lpage>53</lpage>; <lpage>discussion 53-5</lpage>. <pub-id pub-id-type="doi">10.1590/S1677-55382009000100008</pub-id><pub-id pub-id-type="pmid">19254398</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palese</surname><given-names>MA</given-names></name><name><surname>Burnett</surname><given-names>AL</given-names></name></person-group>
<article-title>Corporoplasty using pericardium allograft (tutoplast) with complex penile prosthesis surgery.</article-title>
<source>Urology</source>
<year>2001</year>;<volume>58</volume>:<fpage>1049</fpage>-<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/S0090-4295(01)01410-8</pub-id><pub-id pub-id-type="pmid">11744489</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>VK</given-names></name><name><surname>Shah</surname><given-names>GS</given-names></name><name><surname>Mills</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>The management of extensive penile fibrosis: a new technique of 'minimal scar-tissue excision'.</article-title>
<source>Br J Urol</source>
<year>1996</year>;<volume>77</volume>:<fpage>282</fpage>-<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1046/j.1464-410X.1996.84421.x</pub-id><pub-id pub-id-type="pmid">8800900</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herschorn</surname><given-names>S</given-names></name><name><surname>Ordorica</surname><given-names>RC</given-names></name></person-group>
<article-title>Penile prosthesis insertion with corporeal reconstruction with synthetic vascular graft material.</article-title>
<source>J Urol</source>
<year>1995</year>;<volume>154</volume>:<fpage>80</fpage>-<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(01)67233-1</pub-id><pub-id pub-id-type="pmid">7776461</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knoll</surname><given-names>LD</given-names></name><name><surname>Furlow</surname><given-names>WL</given-names></name></person-group>
<article-title>Corporeal reconstruction and prosthetic implantation for impotence associated with non-dilatable corporeal cavernosal fibrosis.</article-title>
<source>Acta Urol Belg</source>
<year>1992</year>;<volume>60</volume>:<fpage>15</fpage>-<lpage>25</lpage>.<pub-id pub-id-type="pmid">1414716</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaeer</surname><given-names>O</given-names></name><name><surname>Shaeer</surname><given-names>A</given-names></name></person-group>
<article-title>Corporoscopic excavation of the fibrosed corpora cavernosa for penile prosethesis implantation: optical corporotomy and trans-corporeal resection, Shaeer's technique.</article-title>
<source>J Sex Med</source>
<year>2007</year>;<volume>4</volume>:<fpage>218</fpage>-<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2006.00348.x</pub-id><pub-id pub-id-type="pmid">17081216</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kang</surname><given-names>MH</given-names></name><etal/></person-group>
<article-title>Implantation of penile prosthesis in a patient with severe corporeal fibrosis induced by cavernosal injection therapy.</article-title>
<source>Int J Impot Res</source>
<year>2002</year>;<volume>14</volume>:<fpage>545</fpage>-<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ijir.3900930</pub-id><pub-id pub-id-type="pmid">12494294</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ralph</surname><given-names>DJ</given-names></name><name><surname>Garaffa</surname><given-names>G</given-names></name><name><surname>Muneer</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>The immediate insertion of a penile prosthesis for acute ischaemic priapism.</article-title>
<source>Eur Urol</source>
<year>2009</year>;<volume>56</volume>:<fpage>1033</fpage>-<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2008.09.044</pub-id><pub-id pub-id-type="pmid">18930579</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trost</surname><given-names>L</given-names></name><name><surname>Patil</surname><given-names>M</given-names></name><name><surname>Kramer</surname><given-names>A.</given-names></name></person-group>
<article-title>Critical Appraisal and Review of Management Strategies for Severe Fibrosis During Penile Implant Surgery.</article-title>
<source>J Sex Med</source>
<year>2015</year>;<volume>12</volume>
<issue>Suppl 7</issue>:<fpage>439</fpage>-<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1111/jsm.12985</pub-id><pub-id pub-id-type="pmid">26565574</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durazi</surname><given-names>MH</given-names></name><name><surname>Jalal</surname><given-names>AA</given-names></name></person-group>
<article-title>Penile prosthesis implantation for treatment of postpriapism erectile dysfunction.</article-title>
<source>Urol J</source>
<year>2008</year>;<volume>5</volume>:<fpage>115</fpage>-<lpage>9</lpage>.<pub-id pub-id-type="pmid">18592465</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>RW</given-names></name><name><surname>Kalsi</surname><given-names>J</given-names></name><name><surname>Minhas</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>The management of low-flow priapism with the immediate insertion of a penile prosthesis.</article-title>
<source>BJU Int</source>
<year>2002</year>;<volume>90</volume>:<fpage>893</fpage>-<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1046/j.1464-410X.2002.03058.x</pub-id><pub-id pub-id-type="pmid">12460352</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedigh</surname><given-names>O</given-names></name><name><surname>Rolle</surname><given-names>L</given-names></name><name><surname>Negro</surname><given-names>CL</given-names></name><etal/></person-group>
<article-title>Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature.</article-title>
<source>Int J Impot Res</source>
<year>2011</year>;<volume>23</volume>:<fpage>158</fpage>-<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/ijir.2011.23</pub-id><pub-id pub-id-type="pmid">21654814</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>EA</given-names></name><name><surname>El Aasser</surname><given-names>O</given-names></name></person-group>
<article-title>Management of ischemic priapism by penile prosthesis insertion: prevention of distal erosion.</article-title>
<source>J Urol</source>
<year>2010</year>;<volume>183</volume>:<fpage>2300</fpage>-<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2010.02.014</pub-id><pub-id pub-id-type="pmid">20400140</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacharakis</surname><given-names>E</given-names></name><name><surname>Garaffa</surname><given-names>G</given-names></name><name><surname>Raheem</surname><given-names>AA</given-names></name><etal/></person-group>
<article-title>Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation.</article-title>
<source>BJU Int</source>
<year>2014</year>;<volume>114</volume>:<fpage>576</fpage>-<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1111/bju.12686</pub-id><pub-id pub-id-type="pmid">25383397</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tausch</surname><given-names>TJ</given-names></name><name><surname>Zhao</surname><given-names>LC</given-names></name><name><surname>Morey</surname><given-names>AF</given-names></name><etal/></person-group>
<article-title>Malleable penile prosthesis is a cost-effective treatment for refractory ischemic priapism.</article-title>
<source>J Sex Med</source>
<year>2015</year>;<volume>12</volume>:<fpage>824</fpage>-<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/jsm.12803</pub-id><pub-id pub-id-type="pmid">25536880</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>HR</given-names></name><name><surname>Segal</surname><given-names>RL</given-names></name><name><surname>Bivalacqua</surname><given-names>TJ</given-names></name></person-group>
<article-title>Management of priapism: an update for clinicians.</article-title>
<source>Ther Adv Urol</source>
<year>2014</year>;<volume>6</volume>:<fpage>230</fpage>-<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1177/1756287214542096</pub-id><pub-id pub-id-type="pmid">25435917</pub-id></mixed-citation></ref></ref-list></back></article>